Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MIRTAZAPINE SANDOZ ORODISPERSIBLE TAB 15MG - PPB Drug Approval Details

Approvals/PPB/MIRTAZAPINE SANDOZ ORODISPERSIBLE TAB 15MG

Approved

STANDARD

MIRTAZAPINE SANDOZ ORODISPERSIBLE TAB 15MG

SANDOZ HONG KONG LIMITED🇰🇪 Pharmacy and Poisons Board

Approval Date: Jun 21, 2024
Approval ID: 06d3e66bf652d448
Company: SANDOZ HONG KONG LIMITED
Type: Standard

Approval Details

Approval Id: 06d3e66bf652d448
Product Name: MIRTAZAPINE SANDOZ ORODISPERSIBLE TAB 15MG
Drug Hk Name: MIRTAZAPINE SANDOZ ORODISPERSIBLE TAB 15MG
Registration Code: HK-57603
Company Name: SANDOZ HONG KONG LIMITED
Company Detail Path: /organization/sandoz-hong-kong-limited
Registration Category: Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement: Prescription only Medicines
Registration Date: 2009-02-23
Company Address: UNIT 2901, NO. 28 STANLEY STREET, CENTRAL, HONG KONG

Active Ingredients

Approved

Quick Info

Agency

PPB

Country

🇰🇪

Approval Date

Jun 21, 2024

Approval ID

06d3e66bf652d448

Type

Standard

Back to PPB Approvals